Saxenda vs Wegovy: daily or weekly weight-loss jab
Saxenda and Wegovy are two real prescription weight-loss injections from the same family of medicines called GLP-1 receptor agonists. Saxenda is a daily liraglutide jab that gave about 8% weight loss in its big study. Wegovy is a weekly semaglutide jab that gave about 15% in its big study. More average loss on Wegovy, but bigger is not automatically better for you. This honest, India-friendly comparison helps you walk into your doctor's clinic with clear questions, not a decision made from a headline.
You may have heard about two weight-loss injections from the same company, Novo Nordisk. One is called Saxenda, taken every day. The other is called Wegovy, taken once a week. Both are real prescription medicines, not magic. Both help you feel less hungry so you eat a bit less, and both work best with a simple diet and daily movement. People often ask: is the newer weekly one always better, and is the daily one now old news? The honest answer is: not always. This article compares them plainly, so you can walk into your doctor's clinic with clear questions. Your doctor decides what fits your body, your life, and your budget.
The baseline: both are GLP-1 shots, but one is daily and one is weekly
Both Saxenda and Wegovy belong to the same family of medicines called GLP-1 receptor agonists. They copy a hormone your gut makes after a meal, telling your brain you are full. Saxenda's active drug is liraglutide, injected under the skin once daily, building up over five weeks to a 3 mg daily dose. Wegovy's active drug is semaglutide, injected under the skin once weekly, building up over sixteen to twenty weeks to a 2.4 mg weekly dose. In the big studies, Saxenda gave about 8% weight loss over 56 weeks (about 8.4 kg in the SCALE trial). Wegovy gave about 15% weight loss over 68 weeks (14.9% in the STEP 1 trial). More average loss on Wegovy, but the studies ran longer and the drugs are different molecules. Both carry the same family risks. Nausea, diarrhoea, and vomiting are very common, especially in the first weeks. Rare but serious risks include pancreatitis, gallbladder trouble, and kidney injury. Both carry a boxed warning about a possible risk of thyroid C-cell tumours seen in rodents, and both are not for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Neither is for pregnancy. Talk to your doctor before starting or stopping either.
The newer weekly Wegovy is always better, and the daily Saxenda is now obsolete.
VerdictNot necessarily. Wegovy does show more average weight loss in its trial (about 15% vs about 8%) and the once-weekly jab is easier to stick with for many people. That is a real advantage, and it is fine if your doctor points you there. But 'more loss' is not automatically 'better for you.' Side effects, how well you tolerate the drug, cost, and whether you can keep to the routine all matter. Saxenda has been used since 2014, so doctors have more years of real-world experience with it, including in teenagers. Some people do fine on a daily jab and like the lower-intensity buildup. Others find a daily shot too hard and do better on weekly. Both need the same backbone: a reduced-calorie diet and more daily movement. Neither works alone. The right choice is the one your doctor matches to your health, your tolerability, your life, and your wallet, not just the bigger trial number.
Practical points before you and your doctor decide
- Let your doctor choose. These are prescription medicines, not over-the-counter. Your doctor checks your BMI, health conditions, family history, and other medicines before picking daily or weekly.
- Daily vs weekly routine. A daily jab becomes a habit like brushing teeth, but it is about 365 shots a year. A weekly jab is about 52. Think honestly about what you will actually stick with.
- Both need diet and movement. No GLP-1 medicine works alone. You still eat a bit less, walk more, and sleep well. The jab makes the deficit easier, not automatic.
- Expect stomach upset early. Nausea, diarrhoea, and vomiting are common in the first weeks, then usually ease. Start low and build up on the schedule your doctor gives. Tell your doctor if it does not settle.
- Know the red flags. Severe stomach pain that goes through to your back can mean pancreatitis. Stop and get medical help fast. Tell your doctor about any neck lump, trouble swallowing, or shortness of breath.
- Cost and availability in India. Liraglutide has been available longer and may be easier to find, but prices vary widely and change often. Ask your doctor about current cost and supply before you decide.
- Not for pregnancy. Both medicines are not to be used in pregnancy. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
The bottom line
Both Saxenda and Wegovy are real GLP-1 weight-loss medicines from the same family. Saxenda is a daily liraglutide jab with about 8% average weight loss and more years of real-world use. Wegovy is a weekly semaglutide jab with about 15% average weight loss and a lighter injection burden. More loss on Wegovy sounds bigger, but bigger is not automatically better for you. Your tolerability, your routine, your cost, and your health all count. Both carry the same family risks, both need diet and movement, and both are not for pregnancy or for people with MTC or MEN 2. The honest takeaway: there is no 'obsolete' here. The daily option and the weekly option are both real tools. Your doctor picks the one that fits your life. Walk in with questions, not with a decision made from a headline.